Cardiovascular comorbidities of type 2 diabetes mellitus: Defining the potential of glucagonlike peptide1-based therapies

Robert Chilton, Jamison Wyatt, Shailesh Nandish, Rene Oliveros, Michael Lujan

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiovascular comorbidities of type 2 diabetes mellitus: Defining the potential of glucagonlike peptide1-based therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences